NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 65 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $5,000 | -73.7% | 1,939 | -73.1% | 0.00% | – |
Q4 2020 | $19,000 | -32.1% | 7,203 | -36.1% | 0.00% | – |
Q3 2020 | $28,000 | +133.3% | 11,273 | +218.4% | 0.00% | – |
Q2 2020 | $12,000 | +1100.0% | 3,540 | +972.7% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | – | 330 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 330 | -98.7% | 0.00% | – |
Q1 2019 | $51,000 | -1.9% | 25,330 | -37.4% | 0.00% | – |
Q4 2018 | $52,000 | +57.6% | 40,464 | +202.7% | 0.00% | – |
Q3 2018 | $33,000 | -95.4% | 13,367 | -93.7% | 0.00% | – |
Q2 2018 | $710,000 | +22.2% | 211,559 | +54.1% | 0.00% | – |
Q1 2018 | $581,000 | +1136.2% | 137,330 | +858.3% | 0.00% | – |
Q4 2017 | $47,000 | 0.0% | 14,330 | +16.2% | 0.00% | – |
Q3 2017 | $47,000 | -47.2% | 12,330 | -39.4% | 0.00% | – |
Q2 2017 | $89,000 | +8800.0% | 20,330 | +6060.6% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | -97.8% | 330 | -97.6% | 0.00% | – |
Q3 2016 | $45,000 | +4400.0% | 13,905 | +3333.3% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 405 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 405 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | – | 405 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Citizens Financial Corp | 35,100 | $18,428 | 0.01% |
DF DENT & CO INC | 75,000 | $39,375 | 0.00% |
One Day In July LLC | 10,000 | $5,250 | 0.00% |
Cubic Asset Management, LLC | 10,000 | $5,250 | 0.00% |
Steward Financial Group LLC | 100 | $0 | 0.00% |